These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 35569438)
1. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study. Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A; Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438 [TBL] [Abstract][Full Text] [Related]
2. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Martinelli F; Quinten C; Maringwa JT; Coens C; Vercauteren J; Cleeland CS; Flechtner H; Gotay C; Greimel E; King M; Mendoza T; Osoba D; Reeve BB; Ringash J; Koch JS; Shi Q; Taphoorn MJ; Weis J; Bottomley A; Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):587-99. PubMed ID: 21958103 [TBL] [Abstract][Full Text] [Related]
3. Association between Geriatric 8 frailty and health-related quality of life in older patients with cancer (PROGNOSIS-G8): a Danish single-centre, prospective cohort study. Ditzel HM; Giger AW; Lund CM; Ditzel HJ; Möller S; Pfeiffer P; Ryg J; Ewertz M; Jørgensen TL Lancet Healthy Longev; 2024 Sep; 5(9):100612. PubMed ID: 39217995 [TBL] [Abstract][Full Text] [Related]
4. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390 [TBL] [Abstract][Full Text] [Related]
5. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. Park KU Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191 [TBL] [Abstract][Full Text] [Related]
6. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20). Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV; Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189 [TBL] [Abstract][Full Text] [Related]
7. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30. Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469 [TBL] [Abstract][Full Text] [Related]
8. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079 [TBL] [Abstract][Full Text] [Related]
9. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition. Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM; Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909 [TBL] [Abstract][Full Text] [Related]
10. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values. Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722 [TBL] [Abstract][Full Text] [Related]
11. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study. Li Q; Lin Y; Qiu Y; Gao B; Xu Y Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179 [TBL] [Abstract][Full Text] [Related]
12. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Maringwa JT; Quinten C; King M; Ringash J; Osoba D; Coens C; Martinelli F; Vercauteren J; Cleeland CS; Flechtner H; Gotay C; Greimel E; Taphoorn MJ; Reeve BB; Koch JS; Weis J; Smit EF; van Meerbeeck JP; Bottomley A; Support Care Cancer; 2011 Nov; 19(11):1753-60. PubMed ID: 20886240 [TBL] [Abstract][Full Text] [Related]
13. The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. Zikos E; Coens C; Quinten C; Ediebah DE; Martinelli F; Ghislain I; King MT; Gotay C; Ringash J; Velikova G; Reeve BB; Greimel E; Cleeland CS; Flechtner H; Taphoorn MJ; Weis J; Schmucker-von Koch J; Sprangers MA; Bottomley A; J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26714759 [TBL] [Abstract][Full Text] [Related]
14. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients. Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial. Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497 [TBL] [Abstract][Full Text] [Related]
16. Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status? Coomans MB; Dirven L; Aaronson NK; Baumert BG; Van Den Bent M; Bottomley A; Brandes AA; Chinot O; Coens C; Gorlia T; Herrlinger U; Keime-Guibert F; Malmström A; Martinelli F; Stupp R; Talacchi A; Weller M; Wick W; Reijneveld JC; Taphoorn MJB Neuro Oncol; 2019 Nov; 21(11):1447-1457. PubMed ID: 31682733 [TBL] [Abstract][Full Text] [Related]
17. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain. Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486 [TBL] [Abstract][Full Text] [Related]
18. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study. de Ligt KM; Aaronson NK; Liegl G; Nolte S; Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427 [TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in glioma patients in China. Cheng JX; Liu BL; Zhang X; Lin W; Zhang YQ; Liu WP; Zhang JN; Lin H; Wang R; Yin H BMC Cancer; 2010 Jun; 10():305. PubMed ID: 20565883 [TBL] [Abstract][Full Text] [Related]
20. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30. Lundy JJ; Coons SJ; Aaronson NK Patient; 2015 Apr; 8(2):165-70. PubMed ID: 24958466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]